Publication date: September 2026 Source: ESMO Gastrointestinal Oncology, Volume 13, Part B Author(s): P.J.M. Schafrat, J.D.G. Linssen, T.R. de Back, L.E. Nijman, M.C.S. van der Heijden, N.C.T. van Grieken, G. Kazemier, P. Drillenburg, M. Chalabi, F.N. van Erning, I.H.J.T. de Hingh, R.S.A. Goedegebuure, D.W. Sommeijer, A. Farina Sarasqueta, L. Vermeulen
Prognostic significance of CK7, CK20, and CDX2 expression in small intestinal adenocarcinoma. // ESMO Gastrointestinal Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2949819826000464?dgcid=rss_sd_all
Prognostic significance of CK7, CK20, and CDX2 expression in small intestinal adenocarcinoma. ESMO Gastrointestinal Oncology. https://www.sciencedirect.com/science/article/pii/S2949819826000464?dgcid=rss_sd_all
“Prognostic significance of CK7, CK20, and CDX2 expression in small intestinal adenocarcinoma.” ESMO Gastrointestinal Oncology.
@article{article89113,
title = {Prognostic significance of CK7, CK20, and CDX2 expression in small intestinal adenocarcinoma},
journal = {ESMO Gastrointestinal Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2949819826000464?dgcid=rss_sd_all}
}